171 related articles for article (PubMed ID: 32197643)
21. Extracellular matrix stiffness controls VEGF
Bao M; Chen Y; Liu JT; Bao H; Wang WB; Qi YX; Lv F
Angiogenesis; 2022 Feb; 25(1):71-86. PubMed ID: 34170441
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR-296-5p/Bax axis.
Li MM; Liu XH; Zhao YC; Ma XY; Zhou YC; Zhao YX; Liu XY
FEBS J; 2020 Feb; 287(3):561-577. PubMed ID: 31433907
[TBL] [Abstract][Full Text] [Related]
23. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1.
Zhu SY; Wu QY; Zhang CX; Wang Q; Ling J; Huang XT; Sun X; Yuan M; Wu D; Yin HF
Biochem Biophys Res Commun; 2018 Oct; 505(1):309-316. PubMed ID: 30249397
[TBL] [Abstract][Full Text] [Related]
24. RUNX1 promotes MAPK signaling to increase tumor progression and metastasis via OPN in head and neck cancer.
Liu K; Hu H; Jiang H; Zhang H; Gong S; Wei D; Yu Z
Carcinogenesis; 2021 Apr; 42(3):414-422. PubMed ID: 33175152
[TBL] [Abstract][Full Text] [Related]
25. Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation.
Liu S; Xie F; Gan L; Peng T; Xu X; Guo S; Fu W; Wang Y; Ouyang Y; Yang J; Wang X; Zheng Y; Zhang J; Wang H
Genomics; 2020 Nov; 112(6):5343-5355. PubMed ID: 33189780
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
27. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
[TBL] [Abstract][Full Text] [Related]
28. Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.
Voronov D; Gromova A; Liu D; Zoukhri D; Medvinsky A; Meech R; Makarenkova HP
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3115-25. PubMed ID: 23532528
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
Sangpairoj K; Vivithanaporn P; Apisawetakan S; Chongthammakun S; Sobhon P; Chaithirayanon K
Cell Mol Neurobiol; 2017 Oct; 37(7):1243-1255. PubMed ID: 28012022
[TBL] [Abstract][Full Text] [Related]
31. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
Joseph JM; Gross N; Lassau N; Rouffiac V; Opolon P; Laudani L; Auderset K; Geay JF; Mühlethaler-Mottet A; Vassal G
Int J Cancer; 2005 Mar; 113(6):881-90. PubMed ID: 15514941
[TBL] [Abstract][Full Text] [Related]
32. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
33. MiR-223-3p promotes the growth and invasion of neuroblastoma cell via targeting FOXO1.
Han LL; Zhou XJ; Li FJ; Hao XW; Jiang Z; Dong Q; Chen X
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8984-8990. PubMed ID: 31696486
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
Rooney N; Mason SM; McDonald L; Däbritz JHM; Campbell KJ; Hedley A; Howard S; Athineos D; Nixon C; Clark W; Leach JDG; Sansom OJ; Edwards J; Cameron ER; Blyth K
Cancer Res; 2020 Jun; 80(11):2325-2339. PubMed ID: 32156779
[TBL] [Abstract][Full Text] [Related]
35. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.
Chen S; Zhang M; Xing L; Wang Y; Xiao Y; Wu Y
PLoS One; 2015; 10(3):e0121115. PubMed ID: 25811359
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 and cancer.
Lin TC
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188715. PubMed ID: 35271994
[TBL] [Abstract][Full Text] [Related]
39. RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.
Recouvreux MS; Grasso EN; Echeverria PC; Rocha-Viegas L; Castilla LH; Schere-Levy C; Tocci JM; Kordon EC; Rubinstein N
Oncotarget; 2016 Feb; 7(6):6552-65. PubMed ID: 26735887
[TBL] [Abstract][Full Text] [Related]
40. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
